MedTrace Logo

Handheld Ultrasound (HHUS) for Home Use in Hemophilia

NCT04131920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-06-23

No results posted yet for this study

Summary

This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a bleed or not.

Conditions

Interventions

DEVICE

handheld ultrasound: Philips Lumify integrated tele-ultrasound powered by Reacts collaborative platform

Patients receive training by the physical therapist to operate a handheld ultrasound (HHUS) including proper probe placement. Subjects will be tested on their knowledge at the HTC to demonstrate proficiency, and will then repeat the testing at home via tele-ultrasound.

Sponsors & Collaborators

  • Genentech, Inc.

    collaborator INDUSTRY

  • Washington Institute for Coagulation

    lead OTHER

Principal Investigators

  • Rebecca Kruse-Jarres, MD, MPH · Washington Institute for Coagulation

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2022-06-22
Completion
2022-06-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04131920 on ClinicalTrials.gov